Cymabay TherapeuticsCBAY
13F holders, Q1 2024 (March 31)1holders
$32.43avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Cymabay Therapeutics Inc. (CBAY) in their 13F filings. The largest holder was IFP Advisors, Inc ($21K).
- Company
- Cymabay Therapeutics Inc.
- CUSIP
- 23257D103
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 197 | $2.7B |
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | No change | 650 | $21K |
"% of holder's portfolio" is CBAY's weight in each manager's 13F, not the share of Cymabay Therapeutics Inc. the manager owns.